Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  ImmunoGen, Inc.    IMGN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period June 201420152016201720182019
Sales59,985,560,061,063,763,8
Operating income (EBITDA)-66,9-54,4-119-113-124-152
Operating profit (EBIT)-71,5-59,9-124-122-131-145
Pre-Tax Profit (EBT)------
Net income-71,4-60,7-144-146-152-166
P/E ratio-14,3-20,3-1,87-1,19-1,30-1,15
EPS ( $ )-0,83-0,71-1,65-1,67-1,52-1,73
Dividend per Share ( $ )------
Yield------
Reference price ( $ )11.8514.383.081.981.981.98
Announcement Date08/01/2014
10:30am
07/31/2015
10:30am
08/04/2016
02:04pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period June 201420152016201720182019
Debt---146135152
Finance142278245---
Operating income (EBITDA)-66,9-54,4-119-113-124-152
Leverage
(Debt/EBITDA)
----1,28x-1,09x-1,00x
Capital Expenditure8,187,4310,412,713,51,86
Book Value Per Share (BVPS)0,88 $0,41 $-0,93 $-2,28 $-2,15 $-2,32 $
Cash Flow per Share-0,63 $-0,64 $-1,43 $-1,59 $-0,90 $-
Announcement Date08/01/2014
10:30am
07/31/2015
10:30am
08/04/2016
02:04pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 173 M$ -
Entreprise Value (EV) 318 M$ 308 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 2,83x 2,71x
EV / Revenue 5,22x 4,83x
EV / EBITDA -2,81x -2,48x
Yield (DPS / Price) - -
Price to book (Price / BVPS) -0,87x -0,92x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) -200% -205%
operating Leverage (Delta EBIT / Delta Sales) 0,93x -
Net Margin (Net Profit / Revenue) -240% -238%
ROA (Net Profit / Asset) -62,8% -80,2%
ROE (Net Profit / Equities) 104% 85,0%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   20,8% 21,1%
Cash Flow / Sales -227% -123%
Capital Intensity (Assets / Sales) 3,82x 2,97x
Financial Leverage (Net Debt / EBITDA) -1,28x -1,09x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend